Ir al contenido

Oncología

Riesgos e incertidumbres de las transfusiones

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (abre una nueva ventana)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Fuente‎: Surgery 2012;152(3):344-54.

Indexado en‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (abre una nueva ventana)

Perioperative blood transfusions promote pancreas cancer progression. (abre una nueva ventana)

Benson D, Barnett CC Jr.

Fuente‎: J Surg Res 2011;166(2):275-9.

Indexado en‎: PubMed 20828757

DOI‎: 10.1016/j.jss.2010.05.059

https://www.ncbi.nlm.nih.gov/pubmed/20828757 (abre una nueva ventana)

Impact of allogeneic and autologous transfusion on immune function in patients with tumors. (abre una nueva ventana)

Guo JR, Xu F, Jin XJ, Shen HC, Liu Y, Zhang YW, Shao Y.

Fuente‎: Asian Pac J Cancer Prev 2014;15(1):467-74.

Indexado en‎: PubMed 24528076

https://www.ncbi.nlm.nih.gov/pubmed/24528076 (abre una nueva ventana)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (abre una nueva ventana)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Fuente‎: Ann Med Surg (Lond) 2016;6:6-11.

Indexado en‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (abre una nueva ventana)

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. (abre una nueva ventana)

Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.

Fuente‎: Arch Intern Med 2008;168(21):2377-81.

Indexado en‎: PubMed 19029504

DOI‎: 10.1001/archinte.168.21.2377

https://www.ncbi.nlm.nih.gov/pubmed/19029504 (abre una nueva ventana)

Perioperative blood transfusion, age at surgery, and prognosis in a database of 526 upper gastrointestinal cancers. (abre una nueva ventana)

Kosumi K, Baba Y, Harada K, Yoshida N, Watanabe M, Baba H.

Fuente‎: Dig Surg 2015;32(6):445-53.

Indexado en‎: PubMed 26550999

DOI‎: 10.1159/000433609

https://www.ncbi.nlm.nih.gov/pubmed/26550999 (abre una nueva ventana)

Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. (abre una nueva ventana)

Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, Zhou Y, Zhou Y, Zhang Y.

Fuente‎: PLoS One 2013;8(5):e64261.

Indexado en‎: PubMed 23741309

DOI‎: 10.1371/journal.pone.0064261

https://www.ncbi.nlm.nih.gov/pubmed/23741309 (abre una nueva ventana)

Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer. (abre una nueva ventana)

Melis M, McLoughlin JM, Dean EM, Siegel EM, Weber JM, Shah N, Kelley ST, Karl RC.

Fuente‎: J Surg Res 2009;153(1):114-20.

Indexado en‎: PubMed 19201421

DOI‎: 10.1016/j.jss.2008.06.005

https://www.ncbi.nlm.nih.gov/pubmed/19201421 (abre una nueva ventana)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (abre una nueva ventana)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Fuente‎: Cancer Treat Rev 2016;46:1-8.

Indexado en‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (abre una nueva ventana)

Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. (abre una nueva ventana)

Schiergens TS, Rentsch M, Kasparek MS, Frenes K, Jauch KW, Thasler WE.

Fuente‎: Dis Colon Rectum 2015;58(1):74-82.

Indexado en‎: PubMed 25489697

DOI‎: 10.1097/DCR.0000000000000233

https://www.ncbi.nlm.nih.gov/pubmed/25489697 (abre una nueva ventana)